Author:
Prabahar Archana,Shanmugam Latha,Jose Manonmani Alvin,Radhakrishnan Kamaraj Mani,Raja Kalpana
Publisher
Springer International Publishing
Reference58 articles.
1. Ammon A, Rumpf KW, Hommerich CP, Behrens-Baumann W, Rüchel R (1992) Rhinocerebralmucormycosis during deferoxamine therapy. Deutsche medizinischeWochenschrift (1946) 117(38):1434–1438
2. Balhara M, Chaudhary R, Ruhil S, Singh B, Dahiya N, Parmar VS, Jaiwal PK, Chhillar AK (2016) Siderophores; iron scavengers: the novel & promising targets for pathogen specific antifungal therapy. Expert OpinTher Targets 20(12):1477–1489. Epub 2016 Nov 11
3. Bertrand S, Larcher G, Landreau A, Richomme P, Duval O, Bouchara JP (2009) Hydroxamate siderophores of Scedosporiumapiospermum. Biometals 22(6):1019–1029
4. Blatzer M, Schrettl M, Sarg B, Lindner HH, Pfaller K, Haas H (2011) SidL, an Aspergillus fumigatus transacetylase involved in biosynthesis of the siderophores ferricrocin and hydroxyferricrocin. Appl Environ Microbiol 77(14):4959–4966
5. Boelaert JR, Vergauwe PL, Verbanck JJ, Segaert MF (1988) The role of desferrioxamine in dialysis-associated mucormycosis: report of three cases and review of the literature. Clin nephrol 29(5):261–266